| Trial registration number
|
NCT04793243 |
Full text link
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04793243
|
First author
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
José F Muñoz-Valle, Dr.
|
Contact
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-03-11
|
Recruitment status
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- intervention group: patients with positive pcr for covid-19 of both sexes supplemented
with vitamin d
- control group: patients with positive pcr for covid-19 of both sexes
- both groups: mexican individuals, after signing the informed consent letter and over
18 years of age.
|
Exclusion criteria
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
• diseases that compromise the absorption of vitamin d; crohn's disease, cystic fibrosis,
and celiac disease.
|
Number of arms
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
University of Guadalajara
|
Inclusion age min
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Mexico
|
Type of patients
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
No restriction on type of patients
|
Severity scale
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
0: No restriction on type of patients
|
Total sample size
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
42
|
primary outcome
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Baseline levels of serum vitamin D in COVID-19 patients;Correlation between D-dimer and vitamin D serum levels in COVID-19 patients;Correlation between ferritin and vitamin D serum levels in COVID-19 patients;Correlation between transferrin and vitamin D serum levels in COVID-19 patients;Effects of vitamin D3 supplementation on COVID-19 patients
|
Notes
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 1371, "treatment_name": "Vitamin d3", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|